摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

4-(3,4-二氯苯氧基)丁酸 | 3307-37-7

中文名称
4-(3,4-二氯苯氧基)丁酸
中文别名
——
英文名称
4-(3,4-dichlorophenoxy)butanoic acid
英文别名
——
4-(3,4-二氯苯氧基)丁酸化学式
CAS
3307-37-7
化学式
C10H10Cl2O3
mdl
——
分子量
249.094
InChiKey
AKDSUKZFDDKNNM-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    108-110 °C
  • 沸点:
    415.6±35.0 °C(Predicted)
  • 密度:
    1.372±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    15
  • 可旋转键数:
    5
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    46.5
  • 氢给体数:
    1
  • 氢受体数:
    3

安全信息

  • 海关编码:
    2918990090

SDS

SDS:472722bcce3418cd3e9bcc6d6d62eeed
查看

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    4-(3,4-二氯苯氧基)丁酸 在 PPA 作用下, 以 甲苯 为溶剂, 以32%的产率得到7,8-dichloro-3,4-dihydro-2H-benzo[b]oxepin-5-one
    参考文献:
    名称:
    Quaternary salt CCR2 antagonists
    摘要:
    Formula(I)的四价盐化合物或其药用可接受形式,是CCR2拮抗剂,可用于预防、治疗或改善需要的受体中介的炎症综合征、紊乱或疾病。
    公开号:
    US20060293379A1
  • 作为产物:
    描述:
    3,4-二氯苯酚potassium carbonate 、 lithium hydroxide 作用下, 以 四氢呋喃N,N-二甲基甲酰胺 为溶剂, 反应 4.0h, 生成 4-(3,4-二氯苯氧基)丁酸
    参考文献:
    名称:
    Identification of 5-Substituted 2-Acylaminothiazoles That Activate Tat-Mediated Transcription in HIV-1 Latency Models
    摘要:
    The persistent reservoir of cells latently infected with human immunodeficiency virus (HIV)-integrated proviral DNA necessitates lifelong suppressive antiretroviral therapy (ART). Epigenetic targeted compounds have shown promise as potential latency-reversing agents; however, these drugs have undesirable toxicity and lack specificity for HIV. We utilized a novel HEK293-derived FlpIn dual-reporter cell line, which quantifies specific HIV provirus reactivation (LTR promoter) relative to nonspecific host cell gene expression (CMV promoter), to identify the 5-substituted 2-acylaminothiazole hit class. Here, we describe the optimization of the hit class, defining the functionality necessary for HIV gene activation and for improving in vitro metabolism and solubility. The optimized compounds displayed enhanced HIV gene expression in HEK293 and Jurkat 10.6 latency cellular models and increased unspliced HIV RNA in resting CD4+ T cells isolated from HIV-infected individuals on ART, demonstrating the potential of the 2-acylaminothiazole class as latency-reversing agents.
    DOI:
    10.1021/acs.jmedchem.9b00462
点击查看最新优质反应信息

文献信息

  • [EN] QUATERNARY SALT CCR2 ANTAGONISTS<br/>[FR] ANTAGONISTES DE CCR2 A BASE DE SELS QUATERNAIRES
    申请人:JANSSEN PHARMACEUTICA NV
    公开号:WO2006012135A1
    公开(公告)日:2006-02-02
    Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
    Formula (I)的四价盐化合物或其药学上可接受的形式,其为CCR2拮抗剂,可用于预防、治疗或改善CCR2介导的炎症综合征、疾病或症状。
  • Quaternary salt CCR2 antagonists
    申请人:Lagu Bharat
    公开号:US20060293379A1
    公开(公告)日:2006-12-28
    Quaternary salt compounds of Formula (I) or pharmaceutically acceptable forms thereof, which are CCR2 antagonists and are useful in preventing, treating or ameliorating CCR2 mediated inflammatory syndromes, disorders or diseases in a subject in need thereof.
    Formula(I)的四价盐化合物或其药用可接受形式,是CCR2拮抗剂,可用于预防、治疗或改善需要的受体中介的炎症综合征、紊乱或疾病。
  • [EN] DENDRIMER AND FORMULATIONS THEREOF<br/>[FR] DENDRIMÈRE ET FORMULATIONS DE CEUX-CI
    申请人:STARPHARMA PTY LTD
    公开号:WO2017100856A1
    公开(公告)日:2017-06-22
    The present invention relates to a novel dendrimer. The present invention also relates to formulations comprising the dendrimer with improved characteristics. For instance, the present invention relates to formulations comprising pesticides such as 2- (2,4-dichlorophenoxy)acetic acid with improved characteristics such as reduced crystallisation, compatibility with hard water and an extended shelf life at low temperatures.
    本发明涉及一种新型树状聚合物。本发明还涉及含有具有改进特性的树状聚合物的配方。例如,本发明涉及含有农药(如2-(2,4-二氯苯氧)乙酸)的配方,其改进特性包括减少结晶、与硬水相容以及在低温下延长货架寿命。
  • [EN] COMPOSITIONS CONTAINING IDENTICAL POLYAMINE SALTS OF MIXED ANIONIC PESTICIDES<br/>[FR] COMPOSITIONS CONTENANT DES SELS DE POLYAMINE IDENTIQUES DE PESTICIDES ANIONIQUES MÉLANGÉS
    申请人:BASF SE
    公开号:WO2012059494A1
    公开(公告)日:2012-05-10
    The present invention relates to a composition comprising a first salt, which contains a first anionic pesticide (A1 ) and a cationic polyamine (B), and a second salt, which contains a second anionic pesticide (A2) and a cationic polyamine (B), wherein both salts contain the same cationic polyamine (B), and wherein the cationic polyamine comprises at least two amino groups. It further relates to a method for preparing said comprising the step of contacting the first salt and the second salt. In addition, the invention relates to a method of combating harmful insects and/or phytopathogenic fungi, which comprises contacting plants, seed, soil or habitat of plants in or on which the harmful insects and/or phytopathogenic fungi are growing or may grow, plants, seed or soil to be protected from attack or infestation by said harmful insects and/or phytopathogenic fungi with an effective amount of said composition. It also relates to a method of controlling undesired vegetation, which comprises allowing a herbicidal effective amount of said composition to act on plants, their habitat or on seed of said plants. Finally, the invention relates to seed comprising said composition.
    本发明涉及一种组合物,包括第一盐,其中包含第一阴离子杀虫剂(A1)和阳离子聚胺(B),以及第二盐,其中包含第二阴离子杀虫剂(A2)和阳离子聚胺(B),其中两种盐都含有相同的阳离子聚胺(B),且该阳离子聚胺包含至少两个氨基团。此外,本发明还涉及一种制备该组合物的方法,包括将第一盐和第二盐接触的步骤。此外,本发明还涉及一种用于防治有害昆虫和/或植物病原真菌的方法,包括将该组合物的有效量接触到有害昆虫和/或植物病原真菌正在生长或可能生长的植物、种子、土壤或植物栖息地上,以及用于控制不良植被的方法,包括允许该组合物的除草有效量作用于植物、它们的栖息地或该植物的种子。最后,本发明还涉及包含该组合物的种子。
  • Thickening glyphosate formulations
    申请人:Akzo Nobel N.V.
    公开号:EP2425716A2
    公开(公告)日:2012-03-07
    The present invention generally relates to a glyphosate formulation with enhanced viscosity, said formulation containing a thickening composition comprising at least one nitrogen-containing surfactant.
    本发明一般涉及一种具有更高粘度的草甘膦制剂,所述制剂含有一种增稠组合物,该组合物包含至少一种含氮表面活性剂。
查看更多

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐